These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19609911)

  • 1. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea.
    Kovacs GG; Murrell JR; Horvath S; Haraszti L; Majtenyi K; Molnar MJ; Budka H; Ghetti B; Spina S
    Mov Disord; 2009 Sep; 24(12):1843-7. PubMed ID: 19609911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations.
    Storey K; Johanidesová S; Matěj R; Keller J; Rohan Z; Rusina R
    Neurocase; 2017 Feb; 23(1):5-11. PubMed ID: 27915581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel TARDBP missense mutation caused familial amyotrophic lateral sclerosis with frontotemporal dementia and parkinsonism.
    Chen S; Zhou RL; Zhang W; Che CH; Feng SY; Huang HP; Liu CY; Zou ZY
    Neurobiol Aging; 2021 Nov; 107():168-173. PubMed ID: 34175147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
    Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways.
    Barmada SJ; Finkbeiner S
    Rev Neurosci; 2010; 21(4):251-72. PubMed ID: 21086759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted high-throughput sequencing identifies a TARDBP mutation as a cause of early-onset FTD without motor neuron disease.
    Synofzik M; Born C; Rominger A; Lummel N; Schöls L; Biskup S; Schüle C; Grasshoff U; Klopstock T; Adamczyk C
    Neurobiol Aging; 2014 May; 35(5):1212.e1-5. PubMed ID: 24300238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.
    Rutherford NJ; Zhang YJ; Baker M; Gass JM; Finch NA; Xu YF; Stewart H; Kelley BJ; Kuntz K; Crook RJ; Sreedharan J; Vance C; Sorenson E; Lippa C; Bigio EH; Geschwind DH; Knopman DS; Mitsumoto H; Petersen RC; Cashman NR; Hutton M; Shaw CE; Boylan KB; Boeve B; Graff-Radford NR; Wszolek ZK; Caselli RJ; Dickson DW; Mackenzie IR; Petrucelli L; Rademakers R
    PLoS Genet; 2008 Sep; 4(9):e1000193. PubMed ID: 18802454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.
    Van Deerlin VM; Leverenz JB; Bekris LM; Bird TD; Yuan W; Elman LB; Clay D; Wood EM; Chen-Plotkin AS; Martinez-Lage M; Steinbart E; McCluskey L; Grossman M; Neumann M; Wu IL; Yang WS; Kalb R; Galasko DR; Montine TJ; Trojanowski JQ; Lee VM; Schellenberg GD; Yu CE
    Lancet Neurol; 2008 May; 7(5):409-16. PubMed ID: 18396105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic Mutation of TDP-43 Impairs RNA Processing in a Cell Type-Specific Manner: Implications for the Pathogenesis of ALS/FTLD.
    Imaizumi K; Ideno H; Sato T; Morimoto S; Okano H
    eNeuro; 2022; 9(3):. PubMed ID: 35641224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases.
    Rusina R; Kovacs GG; Fiala J; Hort J; Ridzoň P; Holmerová I; Ströbel T; Matěj R
    BMC Neurol; 2011 May; 11():50. PubMed ID: 21569259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations.
    Del Bo R; Ghezzi S; Corti S; Pandolfo M; Ranieri M; Santoro D; Ghione I; Prelle A; Orsetti V; Mancuso M; Sorarù G; Briani C; Angelini C; Siciliano G; Bresolin N; Comi GP
    Eur J Neurol; 2009 Jun; 16(6):727-32. PubMed ID: 19236453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different clinical and neuropathologic phenotypes of familial ALS with A315E TARDBP mutation.
    Fujita Y; Ikeda M; Yanagisawa T; Senoo Y; Okamoto K
    Neurology; 2011 Oct; 77(15):1427-31. PubMed ID: 21956716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation P112H in the TARDBP gene associated with frontotemporal lobar degeneration without motor neuron disease and abundant neuritic amyloid plaques.
    Moreno F; Rabinovici GD; Karydas A; Miller Z; Hsu SC; Legati A; Fong J; Schonhaut D; Esselmann H; Watson C; Stephens ML; Kramer J; Wiltfang J; Seeley WW; Miller BL; Coppola G; Grinberg LT
    Acta Neuropathol Commun; 2015 Apr; 3():19. PubMed ID: 25853458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontotemporal dementia: implications for understanding Alzheimer disease.
    Goedert M; Ghetti B; Spillantini MG
    Cold Spring Harb Perspect Med; 2012 Feb; 2(2):a006254. PubMed ID: 22355793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypes.
    Caroppo P; Le Ber I; Clot F; Rivaud-Péchoux S; Camuzat A; De Septenville A; Boutoleau-Bretonnière C; Mourlon V; Sauvée M; Lebouvier T; Bonnet AM; Levy R; Vercelletto M; Brice A;
    JAMA Neurol; 2014 Feb; 71(2):208-15. PubMed ID: 24343258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinsonism and frontotemporal dementia: the clinical overlap.
    Espay AJ; Litvan I
    J Mol Neurosci; 2011 Nov; 45(3):343-9. PubMed ID: 21892619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
    Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
    Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.